BioNTech (NASDAQ:BNTX) has agreed to acquire its German rival CureVac (NASDAQ:CVAC) in an all-stock transaction worth nearly ...

With FAANG a little dated, the Magnificent Seven struggling, and markets deeply uncertain, these high-multiple retail ...

Primary Health Properties offered £1.68billion to buy Assura but it argued that its cash and stock bid is now worth more.